🇺🇸 FDA
Patent

US 11292766

Substituted piperidine compound and use thereof

granted A61PA61P25/00

Quick answer

US patent 11292766 (Substituted piperidine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P25/00